Gene · 84939
Papers3,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Concurrent follicular lymphoma and follicular dendritic cell sarcoma: composite neoplasm or transdifferentiation? | J Hematop | 2026 | 42799816 | PubTator, text mining | PubMed |
| Large B-cell lymphoma with IRF4 rearrangement: clinicopathologic heterogeneity across the age spectrum. | J Hematop | 2026 | 42726346 | PubTator, text mining | PubMed |
| Case Report: Sinonasal plasmablastic lymphoma in a human immunodeficiency virus-negative elderly woman diagnosed by immunohistochemistry. | Front Med (Lausanne) | 2026 | 42718890 | PubTator, text mining | PubMed |
| Testicular aggressive B-cell lymphoma with plasmablastic morphology harboring concurrent IGH::MYC and IGH::BCL2 rearrangements. | J Hematop | 2026 | 42704559 | PubTator, text mining | PubMed |
| Pediatric Mediastinal Gray Zone Lymphoma With Germline TET2 Heterozygous Variant. | Pediatr Blood Cancer | 2026 | 42657693 | PubTator, text mining | PubMed |
| Correlation Between Hysteroscopic Findings and Histopathological Evidence of Chronic Endometritis in Reproductive Age Women With Gynecological Disorders. | J Minim Invasive Gynecol | 2026 | 42617996 | PubTator, text mining | PubMed |
| Secondary Diffuse Large B-Cell Lymphoma After Sequential Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Case Report. | Case Rep Hematol | 2026 | 42583136 | PubTator, text mining | PubMed |
| Gastric plasmacytoma with loss of Cd138 expression mimicking extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a case report. | Int J Surg Case Rep | 2026 | 42578155 | PubTator, text mining | PubMed |
| Diversified cell origin of Helicobacter pylori eradication-responsive gastric diffuse large B-cell lymphomas. | J Pathol | 2026 | 42554009 | PubTator, text mining | PubMed |
| Sporadic Burkitt Lymphoma Lacking MYC Protein Expression: A Rare Entity With Diagnostic Pitfalls and Dismal Prognosis. | Am J Surg Pathol | 2026 | 42533724 | PubTator, text mining | PubMed |
| SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma. | Sci Rep | 2026 | 42527418 | PubTator, text mining | PubMed |
| Aggressive Primary Sacral Non-Hodgkin Lymphoma Associated With Systemic Lupus Erythematosus. | J Med Cases | 2026 | 42490758 | PubTator, text mining | PubMed |
| From the archives of MD Anderson Cancer Center: Crystal-storing histiocytosis associated with B-cell lymphoma. | Ann Diagn Pathol | 2026 | 42462588 | PubTator, text mining | PubMed |
| ALK-positive large B-cell lymphoma presenting in the nasal cavity with CLTC::ALK fusion: a case report of alectinib-integrated therapy followed by autologous hematopoietic stem cell transplantation. | Front Oncol | 2026 | 42444814 | PubTator, text mining | PubMed |
| Aggressive Mandibular Plasmablastic Lymphoma in an HIV-Negative Patient: Clinicopathologic and Immunophenotypic Insights From a Rare Oral Case. | Case Rep Dent | 2026 | 42434609 | PubTator, text mining | PubMed |
| AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With Double-Hit MYC and BCL2 or BCL6 and Triple Hit. | Pathol Int | 2026 | 42402152 | PubTator, text mining | PubMed |
| Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report. | Front Oncol | 2026 | 42388640 | PubTator, text mining | PubMed |
| CD20-Negative Primary Intestinal Diffuse Large B-cell Lymphoma With TP53 Mutation in Poorly Controlled Celiac Disease: A Diagnostic Challenge. | Cureus | 2026 | 42382877 | PubTator, text mining | PubMed |
| Utility of liquid-based cytology and cell block obtained by vitrectomy under infusion to diagnose vitreoretinal lymphoma. | Jpn J Ophthalmol | 2026 | 42377388 | PubTator, text mining | PubMed |
| [Diagnostic value of minimal endometrial sampling combined with CD138+MUM-1 dual immunostaining for chronic endometritis in FET cycles: a propensity score matching retrospective cohort study]. | Zhonghua Fu Chan Ke Za Zhi | 2026 | 42373428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84939/papers